<p class="abstract"><strong>Background:</strong> The aim of the study was to determine the incidence of different types of rhinosinusitis in patients attending ENT Department OPD at a tertiary care centre in Ruhelkhand area of Northern India.</p><p class="abstract"><strong>Methods:</strong> This study was done at department of Otorhinolaryngology, RMRI, Bareilly, India, a tertiary-care Teaching hospital. A total number of 39823 patients (22379 females, 17444 males) were included in this study from December 2017 till February 2020. Age range of selected patients was 3 months to 76 years, 3883 patients were having Rhinosinusitis and remaining having other ENT diseases. </p><p class="abstract"><strong>Results:</strong> During 27 months period from December 2017 to February 2020, 39823 patients were seen in the OPD and patients were categorized in different disease groups, like chronic suppurative otitis media and acute suppurative otitis media, upper respiratory tract infections, acute and chronic tonsillitis and pharyngitis. Fourth most common disease group was different types of rhinosinusitis.</p><p class="abstract"><strong>Conclusions:</strong> In this study assessment was done of different ENT patients attending OPD. Chronic rhinosinusitis (46.1%) was the most common type of rhinosinusitis, followed by Acute type (29.7%).</p>
Introduction: Prostatic adenocarcinoma is one of the most frequently diagnosed cancer in adult males which seldom metastasizes to testis. Method: In current study the authors retrospectively analysed the 154 cases of bilateral orchiectomy done as hormonal ablation therapy in cases of prostatic adenocarcinoma. Result: We received a total 154 bilateral orchiectomy specimens of patients with prostatic adenocarcinoma in the period of three years. The Patients presented were from 42-86 year of age with a mean age of 60 years. In most (83.11%) of the cases testes were atrophied, 15.58% cases presented with normal histology and only two cases (1.30%) were reported positive for metastasis in testicles. Interestingly both of our cases also had a low PSA level. Conclusion: Testicular atrophy is the most common histopathological finding in patients of bilateral orchiectomy done for prostatic adenocarcinoma. Testicular metastasis is very rare but its possibility highlights the need for continued monitoring of patients with a history of prostatic cancer for local recurrences as well as metastatic disease. It also shows the importance of detecting metastasis to rare locations such as testicles specially in the setting of low PSA levels.
Introduction: Giant cell tumor of bone involves the epiphysis of long bones commonly. Axial skeleton is the rare site for the tumor. Metastasis of this tumor is very rare which is seen in lungs, lymph nodes and liver. It is extremely rare to find metastasis in the occipital bone. Material and method: A retrospective study of giant cell tumor of bone was done over a period of two years. We found a total of 65 cases in the study period. Each case was analysed according to age, sex and site. Result: A total of 65 cases were studied in two year period. Most of the cases (49.23%) were seen in the third decade and had a little female predilection (55.38%). The most common location in our study was around the knee (70.77%) followed by distal radius and proximal humerus. We also had two cases involving rare location i.e. C7 vertebra and temporal bone. Interestingly one of our cases also presented with pulmonary metastasis followed by occipital bone metastasis six and twenty year after primary tumor respectively. Conclusion: Giant cell tumor of bone is a tumor of epiphysis of long bones but can be found in other parts of other bones too. It is a benign tumor but has the potential for distal metastasis so follow up of the patients is required especially in case of primary tumor of upper limbs. Keywords: Giant cell tumor, Rare location, Skull metastasis.
<p class="abstract"><strong>Background:</strong> The aim of the study was to determine the effect of interlay tympanoplasty on anterior tympanomeatal angle and on puretone average at 1 month, 6 month and 1 year follow up.</p><p class="abstract"><strong>Methods:</strong> This study was done at department of Otorhinolaryngology, RMRI, Bareilly, India, a tertiary-care Teaching hospital. A total number of 187 patients (86 females, 101 males) were included in this study from April 2014 to March 2018. Age range of selected patients was 15 years to 62 years, 133 patients were having subtotal perforation and remaining having perforation in the anterior half extending upto the annulus. </p><p class="abstract"><strong>Results:</strong> The anterior tympanomeatal angle blunting and pure tone audiometry (PTA) at the due follow up time was assessed and results were analyzed in terms of angle of blunting and hearing loss detected by PTA. Anterior tympanomeatal angle (ATA) blunting was categorized in three groups as follows <90<sup>o</sup>,90-120<sup>o </sup>and >120<sup>o</sup>. Only 3 patients were having >120<sup>o </sup>ATA after one year and mean hearing loss (air bone gap) was significantly less after 1 year follow up. There were only 3 patients with remnant perforation, after 1 year of surgery out of 187 cases, with 98.4% success rate.</p><p class="p1"><strong>Conclusions:</strong> Interlay tympanoplasty was significantly effective in repairing anterior and subtotal tympanic membrane perforations with avoidance of blunting at the anterior tympanomeatal angle and achieved good functional results. </p>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.